{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:17:03Z","timestamp":1791515823117,"version":"4.3.4"},"reference-count":70,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The expression of BCL6 in B-cell lymphoma can be deregulated by chromosomal translocations, somatic mutations in the promoter regulatory regions, or reduced proteasome-mediated degradation. FBXO11 was recently identified as a ubiquitin ligase that is involved in the degradation of BCL6, and it is frequently inactivated in lymphoma or other tumors. Here, we show that FBXO11 mutations are found in 23% of patients with Burkitt lymphoma (BL). FBXO11 mutations impaired BCL6 degradation, and the deletion of FBXO11 protein completely stabilized BCL6 levels in human BL cell lines. Conditional deletion of 1 or 2 copies of the FBXO11 gene in mice cooperated with oncogenic MYC and accelerated B-cell lymphoma onset, providing experimental evidence that FBXO11 is a haploinsufficient oncosuppressor in B-cell lymphoma. In wild-type and FBXO11-deficient BL mouse and human cell lines, targeting BCL6 via specific degraders or inhibitors partially impaired lymphoma growth in vitro and in vivo. Inhibition of MYC by the Omomyc mini-protein blocked cell proliferation and increased apoptosis, effects further increased by combined BCL6 targeting. Thus, by validating the functional role of FBXO11 mutations in BL, we further highlight the key role of BCL6 in BL biology and provide evidence that innovative therapeutic approaches, such as BCL6 degraders and direct MYC inhibition, could be exploited as a targeted therapy for BL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005682","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:40:25Z","timestamp":1633912825000},"page":"5239-5257","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2720-4583","authenticated-orcid":false,"given":"Chiara","family":"Pighi","sequence":"first","affiliation":[{"name":"Department of Pathology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA;"},{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0939-9412","authenticated-orcid":false,"given":"Taek-Chin","family":"Cheong","sequence":"additional","affiliation":[{"name":"Department of Pathology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Compagno","sequence":"additional","affiliation":[{"name":"Department of Pathology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA;"},{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-5058","authenticated-orcid":false,"given":"Enrico","family":"Patrucco","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Arigoni","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Olivero","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"},{"name":"Candiolo Cancer Institute , FPO-IRCCS, Candiolo (To), Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4306-3293","authenticated-orcid":false,"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-9449","authenticated-orcid":false,"given":"Stephan H.","family":"Bernhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Grande","sequence":"additional","affiliation":[{"name":"Computational Oncology, Sage Bionetworks, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Poggio","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Langellotto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bonello","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dall\u2019Olio","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4443-0697","authenticated-orcid":false,"given":"Sandra","family":"Mart\u00ednez-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Vall d'Hebron Institute of Oncology, Edifici Cellex, Hospital Vall d'Hebron, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Molinaro","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Citta\u2019 della Salute, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Francia di Celle","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Citta\u2019 della Salute, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4925-7283","authenticated-orcid":false,"given":"Jonathan R.","family":"Whitfield","sequence":"additional","affiliation":[{"name":"Vall d'Hebron Institute of Oncology, Edifici Cellex, Hospital Vall d'Hebron, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-7971","authenticated-orcid":false,"given":"Laura","family":"Soucek","sequence":"additional","affiliation":[{"name":"Vall d'Hebron Institute of Oncology, Edifici Cellex, Hospital Vall d'Hebron, Barcelona, Spain;"},{"name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain;"},{"name":"Department of Biochemistry and Molecular Biology, Universitat Aut\u00f2noma De Barcelona, Bellaterra, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-1431","authenticated-orcid":false,"given":"Claudia","family":"Voena","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2848-628X","authenticated-orcid":false,"given":"Raffaele A.","family":"Calogero","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-7800","authenticated-orcid":false,"given":"Ryan D.","family":"Morin","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research and Biometric Research Program, Division of Cancer Diagnosis and Treatment, National Cancer Institute, National Institutes of Health, Rockville, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zam\u00f2","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Chiarle","sequence":"additional","affiliation":[{"name":"Department of Pathology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA;"},{"name":"Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"issue":"1","key":"2021120816260349900_B1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2012.01112.x","article-title":"Roles of BCL6 in normal and transformed germinal center B cells","volume":"247","author":"Basso","year":"2012","journal-title":"Immunol Rev."},{"issue":"1","key":"2021120816260349900_B2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-immunol-031210-101329","article-title":"Mechanisms that promote and suppress chromosomal translocations in lymphocytes","volume":"29","author":"Gostissa","year":"2011","journal-title":"Annu Rev Immunol."},{"issue":"7337","key":"2021120816260349900_B3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature."},{"issue":"3","key":"2021120816260349900_B4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.coi.2013.05.003","article-title":"New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytes","volume":"25","author":"Bunting","year":"2013","journal-title":"Curr Opin Immunol."},{"key":"2021120816260349900_B5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(10)05007-8","article-title":"BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis","volume":"105","author":"Basso","year":"2010","journal-title":"Adv Immunol."},{"issue":"7379","key":"2021120816260349900_B6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature10688","article-title":"FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas","volume":"481","author":"Duan","year":"2012","journal-title":"Nature."},{"issue":"6","key":"2021120816260349900_B7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.molcel.2013.02.003","article-title":"CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7\/Set8-mediated cellular migration","volume":"49","author":"Abbas","year":"2013","journal-title":"Mol Cell."},{"issue":"6","key":"2021120816260349900_B8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.molcel.2013.02.004","article-title":"Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase","volume":"49","author":"Rossi","year":"2013","journal-title":"Mol Cell."},{"issue":"3","key":"2021120816260349900_B9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1074\/jbc.M609001200","article-title":"FBXO11 promotes the neddylation of p53 and inhibits its transcriptional activity","volume":"282","author":"Abida","year":"2007","journal-title":"J Biol Chem."},{"issue":"4","key":"2021120816260349900_B10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/onc.2015.96","article-title":"MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity","volume":"35","author":"Xue","year":"2016","journal-title":"Oncogene."},{"issue":"1","key":"2021120816260349900_B11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-8417-2-5","article-title":"Regulation of TGF-beta signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant","volume":"2","author":"Tateossian","year":"2009","journal-title":"PathoGenetics."},{"issue":"3","key":"2021120816260349900_B12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ccr.2014.07.022","article-title":"PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis","volume":"26","author":"Zheng","year":"2014","journal-title":"Cancer Cell."},{"issue":"3","key":"2021120816260349900_B13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.devcel.2007.01.018","article-title":"DRE-1: an evolutionarily conserved F box protein that regulates C. elegans developmental age","volume":"12","author":"Fielenbach","year":"2007","journal-title":"Dev Cell."},{"issue":"6","key":"2021120816260349900_B14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.devcel.2014.01.028","article-title":"DRE-1\/FBXO11-dependent degradation of BLMP-1\/BLIMP-1 governs C. elegans developmental timing and maturation","volume":"28","author":"Horn","year":"2014","journal-title":"Dev Cell."},{"issue":"2","key":"2021120816260349900_B15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ajhg.2018.07.003","article-title":"De novo variants in the F-box protein FBXO11 in 20 individuals with a variable neurodevelopmental disorder","volume":"103","author":"Gregor","year":"2018","journal-title":"Am J Hum Genet."},{"issue":"5","key":"2021120816260349900_B16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00439-018-1892-1","article-title":"De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies","volume":"137","author":"Fritzen","year":"2018","journal-title":"Hum Genet."},{"issue":"5","key":"2021120816260349900_B17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41431-018-0292-2","article-title":"De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms","volume":"27","author":"Jansen","year":"2019","journal-title":"Eur J Hum Genet."},{"key":"2021120816260349900_B18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fgene.2020.00498","article-title":"The Jeff mouse mutant model for chronic otitis media manifests gain-of-function as well as loss-of-function effects","volume":"11","author":"Kubinyecz","year":"2020","journal-title":"Front Genet."},{"key":"2021120816260349900_B19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2015.10.003","article-title":"F-box proteins: keeping the epithelial-to-mesenchymal transition (EMT) in check","volume":"36","author":"D\u00edaz","year":"2016","journal-title":"Semin Cancer Biol."},{"issue":"5","key":"2021120816260349900_B20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood-2015-11-684357","article-title":"FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease","volume":"128","author":"Schneider","year":"2016","journal-title":"Blood."},{"issue":"5","key":"2021120816260349900_B21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.celrep.2019.06.079","article-title":"CRISPR\/Cas9 screens reveal multiple layers of B cell CD40 regulation","volume":"28","author":"Jiang","year":"2019","journal-title":"Cell Rep."},{"issue":"12","key":"2021120816260349900_B22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood."},{"issue":"1","key":"2021120816260349900_B23","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","article-title":"Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma","volume":"10","author":"L\u00f3pez","year":"2019","journal-title":"Nat Commun."},{"issue":"19","key":"2021120816260349900_B24","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood."},{"issue":"1","key":"2021120816260349900_B25","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1038\/ncomms5632","article-title":"Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis","volume":"5","author":"Annibali","year":"2014","journal-title":"Nat Commun."},{"issue":"10","key":"2021120816260349900_B26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood-2015-11-683052","article-title":"Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice","volume":"127","author":"Choudhari","year":"2016","journal-title":"Blood."},{"issue":"5","key":"2021120816260349900_B27","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41375-017-0007-7","article-title":"ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation","volume":"32","author":"Malcikova","year":"2018","journal-title":"Leukemia."},{"issue":"484","key":"2021120816260349900_B28","doi-asserted-by":"crossref","first-page":"eaar5012","DOI":"10.1126\/scitranslmed.aar5012","article-title":"Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy","volume":"11","author":"Beaulieu","year":"2019","journal-title":"Sci Transl Med."},{"issue":"5","key":"2021120816260349900_B29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/bioinformatics\/btx674","article-title":"SeqBox: RNAseq\/ChIPseq reproducible analysis on a consumer game computer","volume":"34","author":"Beccuti","year":"2018","journal-title":"Bioinformatics."},{"key":"2021120816260349900_B30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12859-018-2296-x","article-title":"Reproducible bioinformatics project: a community for reproducible bioinformatics analysis pipelines","volume":"19","author":"Kulkarni","year":"2018","journal-title":"BMC Bioinformatics."},{"issue":"19","key":"2021120816260349900_B31","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics."},{"key":"2021120816260349900_B32","doi-asserted-by":"crossref","first-page":"11.14.1","DOI":"10.1002\/0471250953.bi1114s51","article-title":"Mapping RNA-seq reads with STAR","volume":"51","author":"Dobin","year":"2015","journal-title":"Curr Protoc Bioinformatics."},{"issue":"1","key":"2021120816260349900_B33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics."},{"key":"2021120816260349900_B34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.12688\/f1000research.7035.1","article-title":"RNA-Seq workflow: gene-level exploratory analysis and differential expression","volume":"4","author":"Love","year":"2015","journal-title":"F1000 Res."},{"issue":"5","key":"2021120816260349900_B35","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1182\/blood-2009-06-227017","article-title":"Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells","volume":"115","author":"Basso","year":"2010","journal-title":"Blood."},{"key":"2021120816260349900_B36","first-page":"5536","article-title":"The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL","volume-title":"Blood.","author":"Ci","year":"2009"},{"issue":"12","key":"2021120816260349900_B37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"43","key":"2021120816260349900_B38","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"2021120816260349900_B39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet."},{"issue":"12","key":"2021120816260349900_B40","doi-asserted-by":"crossref","first-page":"e83244","DOI":"10.1371\/journal.pone.0083244","article-title":"Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma","volume":"8","author":"Parry","year":"2013","journal-title":"PLoS One."},{"issue":"1","key":"2021120816260349900_B41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ijc.25663","article-title":"BCL6 gene rearrangement and protein expression are associated with large cell presentation of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"129","author":"Flossbach","year":"2011","journal-title":"Int J Cancer."},{"issue":"9","key":"2021120816260349900_B42","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrm1471","article-title":"The SCF ubiquitin ligase: insights into a molecular machine","volume":"5","author":"Cardozo","year":"2004","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"6046","key":"2021120816260349900_B43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature."},{"issue":"2","key":"2021120816260349900_B44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.167.2.353","article-title":"The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells","volume":"167","author":"Harris","year":"1988","journal-title":"J Exp Med."},{"issue":"12","key":"2021120816260349900_B45","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1158\/1535-7163.MCT-13-0044","article-title":"Utilization of the E\u03bc-Myc mouse to model heterogeneity of therapeutic response","volume":"13","author":"Rempel","year":"2014","journal-title":"Mol Cancer Ther."},{"issue":"3","key":"2021120816260349900_B46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat Rev Immunol."},{"issue":"20","key":"2021120816260349900_B47","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"issue":"20","key":"2021120816260349900_B48","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1158\/0008-5472.CAN-08-1329","article-title":"Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma","volume":"68","author":"Mori","year":"2008","journal-title":"Cancer Res."},{"issue":"7017","key":"2021120816260349900_B49","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nature03147","article-title":"The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells","volume":"432","author":"Phan","year":"2004","journal-title":"Nature."},{"issue":"20","key":"2021120816260349900_B50","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","article-title":"Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis","volume":"13","author":"Eischen","year":"1999","journal-title":"Genes Dev."},{"issue":"11","key":"2021120816260349900_B51","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1038\/bcj.2014.75","article-title":"Hypermethylation of the tumor suppressor gene PRDM1\/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma","volume":"4","author":"Zhang","year":"2014","journal-title":"Blood Cancer J."},{"issue":"8","key":"2021120816260349900_B52","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1080\/10428194.2020.1747068","article-title":"Burkitt lymphoma: bridging the gap between advances in molecular biology and therapy","volume":"61","author":"Zayac","year":"2020","journal-title":"Leuk Lymphoma."},{"issue":"9","key":"2021120816260349900_B53","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1172\/JCI85795","article-title":"Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma","volume":"126","author":"Cardenas","year":"2016","journal-title":"J Clin Invest."},{"issue":"12","key":"2021120816260349900_B54","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.celrep.2017.08.081","article-title":"Chemically induced degradation of the oncogenic transcription factor BCL6","volume":"20","author":"Kerres","year":"2017","journal-title":"Cell Rep."},{"issue":"7836","key":"2021120816260349900_B55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41586-020-2925-1","article-title":"Small-molecule-induced polymerization triggers degradation of BCL6","volume":"588","author":"S\u0142abicki","year":"2020","journal-title":"Nature."},{"issue":"8","key":"2021120816260349900_B56","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.celrep.2018.07.055","article-title":"BET inhibition-induced GSK3\u03b2 feedback enhances lymphoma vulnerability to PI3K inhibitors","volume":"24","author":"Derenzini","year":"2018","journal-title":"Cell Rep."},{"issue":"7213","key":"2021120816260349900_B57","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature07260","article-title":"Modelling Myc inhibition as a cancer therapy","volume":"455","author":"Soucek","year":"2008","journal-title":"Nature."},{"issue":"4","key":"2021120816260349900_B58","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","article-title":"BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma","volume":"102","author":"Akasaka","year":"2003","journal-title":"Blood."},{"key":"2021120816260349900_B59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1749-6632.1987.tb36249.x","article-title":"Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis","volume":"511","author":"Dalla-Favera","year":"1987","journal-title":"Ann N Y Acad Sci."},{"issue":"2","key":"2021120816260349900_B60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia."},{"issue":"40","key":"2021120816260349900_B61","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","article-title":"Mechanisms of chromosomal translocations in B cell lymphomas","volume":"20","author":"K\u00fcppers","year":"2001","journal-title":"Oncogene."},{"issue":"12","key":"2021120816260349900_B62","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet."},{"issue":"7418","key":"2021120816260349900_B63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature."},{"issue":"5","key":"2021120816260349900_B64","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic Burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol Cancer Res."},{"issue":"3","key":"2021120816260349900_B65","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1074\/jbc.M808080200","article-title":"TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1","volume":"284","author":"Spender","year":"2009","journal-title":"J Biol Chem."},{"issue":"5","key":"2021120816260349900_B66","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.4049\/jimmunol.165.5.2500","article-title":"Apoptosis induced by TGF-beta 1 in Burkitt\u2019s lymphoma cells is caspase 8 dependent but is death receptor independent","volume":"165","author":"Inman","year":"2000","journal-title":"J Immunol."},{"issue":"5","key":"2021120816260349900_B67","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.chom.2017.04.005","article-title":"CRISPR\/Cas9 screens reveal Epstein-Barr virus-transformed B cell host dependency factors","volume":"21","author":"Ma","year":"2017","journal-title":"Cell Host Microbe."},{"issue":"2","key":"2021120816260349900_B68","doi-asserted-by":"crossref","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"1","key":"2021120816260349900_B69","doi-asserted-by":"crossref","first-page":"16495","DOI":"10.1038\/s41598-019-52714-4","article-title":"Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells","volume":"9","author":"Cortiguera","year":"2019","journal-title":"Sci Rep."},{"issue":"6","key":"2021120816260349900_B70","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/23\/5239\/1850043\/advancesadv2021005682.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/23\/5239\/1850043\/advancesadv2021005682.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T16:28:37Z","timestamp":1638980917000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/23\/5239\/477241\/Frequent-mutations-of-FBXO11-highlight-BCL6-as-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":70,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,12,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005682","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]}}}